• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性中的隐匿性视网膜下新生血管。自然病程及早期激光治疗。

Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment.

作者信息

Soubrane G, Coscas G, Français C, Koenig F

机构信息

Clinique Ophthalmologique Universitaire de Créteil, Universite de Paris XII.

出版信息

Ophthalmology. 1990 May;97(5):649-57. doi: 10.1016/s0161-6420(90)32530-7.

DOI:10.1016/s0161-6420(90)32530-7
PMID:2342811
Abstract

Little information is available on the natural history and no data have been published on laser treatment for occult neovascularization in age-related macular degeneration. The visual and angiographic outcomes were analyzed in 156 patients (82 untreated eyes; 81 treated eyes) with occult neovascularization who were followed for 1 to 8 years. Early laser treatment decreased visual acuity to less than 20/200 in 31 of the treated eyes (38%) compared with 20 of the untreated eyes (25%). Three years after the onset of symptoms, 24 treated eyes (29%) and 31 eyes untreated eyes (38%) retained 20/50 visual acuity or better, whereas their respective initial visual acuities were not statistically different. Severe loss of vision (6 or more lines of visual acuity) occurred in 43 treated eyes (53%) and in 33 untreated eyes (40%) at the end of follow-up (range, 12-84 months). A slow and gradual increase of the disciform lesion was demonstrated on fluorescein angiography in 60 untreated eyes, with subfoveal involvement noted in 39 eyes at the end of follow-up. In the treated group, subfoveal involvement occurred in 53 eyes, after a relatively short time (mean, 4 months). Only 28 of the 81 treated eyes had successful anatomic results. These findings suggested that laser treatment of occult neovascularization immediately after the onset of symptoms should not be recommended.

摘要

关于年龄相关性黄斑变性隐匿性新生血管的自然病史,目前所知甚少,且尚无关于激光治疗的相关数据发表。对156例隐匿性新生血管患者(82只未治疗眼;81只治疗眼)进行了1至8年的随访,并分析了其视力和血管造影结果。与20只未治疗眼(25%)相比,早期激光治疗使31只治疗眼(38%)的视力下降至20/200以下。症状出现三年后,24只治疗眼(29%)和31只未治疗眼(38%)的视力保持在20/50或更好,而它们各自的初始视力无统计学差异。随访结束时(随访时间为12 - 84个月),43只治疗眼(53%)和33只未治疗眼(40%)出现了严重视力丧失(视力下降6行或更多)。60只未治疗眼在荧光素血管造影中显示盘状病变缓慢逐渐增加,随访结束时39只眼出现黄斑中心凹受累。在治疗组中,黄斑中心凹受累发生在53只眼中,时间相对较短(平均4个月)。81只治疗眼中只有28只获得了成功的解剖学结果。这些发现表明,不建议在症状出现后立即对隐匿性新生血管进行激光治疗。

相似文献

1
Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment.年龄相关性黄斑变性中的隐匿性视网膜下新生血管。自然病程及早期激光治疗。
Ophthalmology. 1990 May;97(5):649-57. doi: 10.1016/s0161-6420(90)32530-7.
2
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.维替泊芬治疗年龄相关性黄斑变性中心凹下脉络膜新生血管:一项随机临床试验的两年结果,该试验纳入隐匿性无典型脉络膜新生血管病变——维替泊芬光动力疗法报告2
Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9.
3
Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.年龄相关性黄斑变性中黄斑下复发性新生血管病变的激光光凝治疗。一项随机临床试验的结果。黄斑光凝研究组。
Arch Ophthalmol. 1991 Sep;109(9):1232-41. doi: 10.1001/archopht.1991.01080090056026.
4
Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.年龄相关性黄斑变性中心凹下新生血管病变的激光光凝治疗。两项临床试验的最新结果。黄斑光凝研究组。
Arch Ophthalmol. 1993 Sep;111(9):1200-9. doi: 10.1001/archopht.1993.01090090052019.
5
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.维替泊芬光动力疗法治疗年龄相关性黄斑变性的中心凹下脉络膜新生血管:两项随机临床试验的一年结果——TAP报告。年龄相关性黄斑变性光动力疗法(TAP)研究组
Arch Ophthalmol. 1999 Oct;117(10):1329-45.
6
Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.年龄相关性黄斑变性患者隐匿性黄斑中心凹下脉络膜新生血管的经瞳孔温热疗法
Ophthalmology. 1999 Oct;106(10):1908-14. doi: 10.1016/S0161-6420(99)90400-1.
7
Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration.年龄相关性黄斑变性继发中心凹下脉络膜新生血管眼的扫描激光检眼镜微视野检查法所致视力丧失的特征
Am J Ophthalmol. 2003 Dec;136(6):1067-78. doi: 10.1016/s0002-9394(03)00663-9.
8
Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
Arch Ophthalmol. 1991 Sep;109(9):1220-31. doi: 10.1001/archopht.1991.01080090044025.
9
Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration.年龄相关性黄斑变性中黄斑中心凹下视网膜下出血的自然病程。
Retina. 1996;16(3):183-9. doi: 10.1097/00006982-199616030-00001.
10
Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.年龄相关性黄斑变性中边界不清的黄斑下脉络膜新生血管的黄斑散射(“格栅样”)激光治疗。一项随机试验的结果
Arch Ophthalmol. 1996 Dec;114(12):1456-64. doi: 10.1001/archopht.1996.01100140654002.

引用本文的文献

1
Impact of optical coherence tomography angiography on the non-invasive diagnosis of neovascular age-related macular degeneration.光学相干断层扫描血管造影对新生血管性年龄相关性黄斑变性的无创诊断的影响。
Graefes Arch Clin Exp Ophthalmol. 2020 Mar;258(3):537-541. doi: 10.1007/s00417-019-04581-y. Epub 2020 Jan 3.
2
Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience.雷珠单抗治疗新生血管性年龄相关性黄斑变性的五年疗效:真实临床经验
Korean J Ophthalmol. 2017 Oct;31(5):424-430. doi: 10.3341/kjo.2016.0125. Epub 2017 Sep 11.
3
Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study.
追踪新生血管性年龄相关性黄斑变性患者视力和生活质量的自然病程:一项系统评价和生活质量研究
BMC Ophthalmol. 2017 Jul 11;17(1):120. doi: 10.1186/s12886-017-0514-3.
4
The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.吲哚菁绿血管造影成像在现实环境中对雷珠单抗形态学反应不佳的新生血管性年龄相关性黄斑变性患者进一步鉴别诊断中的作用。
Eye (Lond). 2016 Jul;30(7):958-65. doi: 10.1038/eye.2016.71. Epub 2016 Apr 15.
5
Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration.改善新生血管性年龄相关性黄斑变性早期检测与诊断的策略
Clin Ophthalmol. 2015 Feb 17;9:353-66. doi: 10.2147/OPTH.S59012. eCollection 2015.
6
Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性中光学相干断层扫描视网膜参数与视力的关系
Ophthalmology. 2008 Dec;115(12):2206-14. doi: 10.1016/j.ophtha.2008.08.016. Epub 2008 Oct 18.
7
Relationship between foveal birefringence and visual acuity in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性中黄斑中心凹双折射与视力的关系
Eye (Lond). 2007 Mar;21(3):353-61. doi: 10.1038/sj.eye.6702203. Epub 2006 Jan 6.
8
[Transpupillary thermotherapy for subfoveal choroidal neovascularization. A 9-month follow-up].[经瞳孔温热疗法治疗黄斑中心凹下脉络膜新生血管。9个月随访]
Ophthalmologe. 2004 Nov;101(11):1105-10. doi: 10.1007/s00347-004-1114-1.
9
A pilot study of ICG-guided laser photocoagulation for occult choroidal neovascularization presenting as a focal spot in age-related macular degeneration.吲哚菁绿引导的激光光凝治疗年龄相关性黄斑变性中表现为焦点状的隐匿性脉络膜新生血管的初步研究。
Int Ophthalmol. 2001;24(4):187-94. doi: 10.1023/a:1022539204849.
10
Age-related macular degeneration: epidemiology and optimal treatment.年龄相关性黄斑变性:流行病学与最佳治疗方法
Drugs Aging. 2002;19(2):101-33. doi: 10.2165/00002512-200219020-00003.